GeneNews to Raise C$7.7M in Private Placement | GenomeWeb

NEW YORK (GenomeWeb News) – GeneNews today said that it expects to raise gross proceeds of C$7.7 million (US$7.8 million) through a private placement of its common shares.

The Toronto-based molecular diagnostics developer said that it has accepted subscriptions for a non-brokered private placement of its shares. The firm said that the offering will result in the issuance of around 86.3 million common shares from treasury at a price of C$.09 per share.

GeneNews noted that the size of offering was increased from an initial C$6 million target "due to strong demand."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."